Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
The current price of CTKB is $4.78 USD — it has increased by +2.58% in the past 24 hours. Watch Cytek BioSciences stock price performance more closely on the chart.
What is Cytek BioSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cytek BioSciences stocks are traded under the ticker CTKB.
Is Cytek BioSciences stock price growing?▼
CTKB stock has risen by +7.66% compared to the previous week, the month change is a +5.75% rise, over the last year Cytek BioSciences has showed a +29.89% increase.
What is Cytek BioSciences market cap?▼
Today Cytek BioSciences has the market capitalization of 611.19M
When is the next Cytek BioSciences earnings date?▼
Cytek BioSciences is going to release the next earnings report on May 07, 2026.
What were Cytek BioSciences earnings last quarter?▼
CTKB earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.02 USD resulting in a -1,600% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cytek BioSciences revenue for the last year?▼
Cytek BioSciences revenue for the last year amounts to 400.91M USD.
What is Cytek BioSciences net income for the last year?▼
CTKB net income for the last year is -12.04M USD.
How many employees does Cytek BioSciences have?▼
As of May 06, 2026, the company has 663 employees.
In which sector is Cytek BioSciences located?▼
Cytek BioSciences operates in the Health & Wellness sector.
When did Cytek BioSciences complete a stock split?▼
Cytek BioSciences has not had any recent stock splits.
Where is Cytek BioSciences headquartered?▼
Cytek BioSciences is headquartered in Fremont, United States.